NeuroSense Therapeutics
als is a rapidly progressing fatal disease with a huge unmet need for new treatment options | NeuroSense Therapeutics
Deck date
October 2024
Slide
7 of 27
Related slides by other companies
Investor Day
November 2022
Results
February 2024
Results
April 2022
Other recent decks by NeuroSense Therapeutics
Investor Presentation
January 2024
Investor Presentation
December 2023
Investor Presentation
June 2023
Search Thousands of Presentations by World Leading Companies